Lumen composition (mucus and microbiota) |
Inhibition of mucus synthesis by interference with epidermal grow factor (EGF) expression and polyamines synthesis. |
Gastric and peptic ulcer |
(10, 11) |
Alteration on mucus composition, related with an increment on Muc2 and Muc3 expression in the ileum and Muc4 expression in the colon. |
IBD |
(12) |
Dysbiosis of gut resident microbiota, with an increase of Firmicutes and Actinobacteria and a decrease of Bacteroidetes and Proteobacteria. |
IBD |
(13, 14) |
Integrity of mucosa composition |
Impaired barrier of the small intestine due to increase of intestinal permeability and alteration of tight junctions. |
CD |
(15) |
Inhibition of angiogenesis during ulcer healing by dysregulation of nitric oxide (NO) production. |
Gastric ulcer |
(10, 16) |
Alteration of microvasculature, impairing vascular endothelial grown factor (VEGF) pathway, promotes ischemia in the gut. |
Gastric ulcer and CD |
(10, 15) |
Cellular apoptosis due to increased reactive oxygen species and mechanical effects. |
Gastric, esophageal and colon cancer |
(17–19) |
Effects related with immune response |
Induction of proinflammatory chemokines and cytokines (CCR6, CCL20, IL-8) in the ileum. |
CD |
(20) |
Alteration of dendritic cell phenotype including an increase in the expression of MHC-II and costimulatory molecules. |
UC |
(21) |
Increased recruitment of CD4+ and CD8+ T cells, and of CD11b+ dendritic cells on Ileum. |
CD |
(19, 22) |